BioSpace News Archive

Business

CTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its third quarter 2022 financial results on Monday, November 7, 2022, after the close of the U.S. financial markets.

October 27, 2022
·
1 min read
Business

Acutus Medical to Announce Third Quarter 2022 Financial Results

Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2022 financial results on Thursday, November 10, 2022.

October 27, 2022
·
1 min read
Deals

Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty

Agios Pharmaceuticals, Inc. and Sagard Healthcare Partners announced that Agios has sold its rights to 5% royalties on U.S. net sales of Servier’s TIBSOVO® to Sagard for a one-time payment of $131.8 million.

October 27, 2022
·
6 min read
Biotech Beach

Connect Biopharma To Present at Upcoming Investor and Scientific Conferences - October 27, 2022

Connect Biopharma Holdings Limited announced it will be presenting and/or hosting one-on-one meetings at the following upcoming investor and scientific conferences:

October 27, 2022
·
2 min read
Biotech Bay

Rila Therapeutics Exits Stealth Mode

Rila Therapeutics, a biotherapeutics company focused on addressing the critical unmet medical needs to treat renal fibrosis, announced its emergence out of stealth mode.

October 27, 2022
·
4 min read
Business

Vertex Reports Third Quarter 2022 Financial Results

Vertex Pharmaceuticals Incorporated reported consolidated financial results for the third quarter ended September 30, 2022 and increased its full year 2022 revenue guidance.

October 27, 2022
·
26 min read
Business

Seagen Reports Third Quarter 2022 Financial Results

Seagen Inc. (Nasdaq:SGEN) reported financial results today for the third quarter ended September 30, 2022.

October 27, 2022
·
16 min read
Business

argenx Reports Third Quarter 2022 Financial Results and Provides Business Update

argenx SE announced its third quarter 2022 financial results and provided a business update and outlook for the remainder of the year.

October 27, 2022
·
15 min read
Bio NC

FUJIFILM Diosynth Biotechnologies Enters Into an Agreement with Argenx to Manufacture Efgartigimod, a monoclonal antibody (mAb) for the Treatment of Severe Autoimmune Diseases

FUJIFILM Diosynth Biotechnologies announced an agreement with argenx to manufacture efgartigimod, a monoclonal antibody fragment to target the neonatal Fc receptor, in patients with severe autoimmune disease.

October 27, 2022
·
3 min read
Genetown

Pandemic Protect Deployed in Massachusetts as COVID-19 Cases Rise

Quantgene, a medical intelligence firm specializing in precision medicine and advanced COVID-19 solutions, is now offering Pandemic Protect throughout Massachusetts as COVID-19 cases rise.

October 27, 2022
·
3 min read